Chen En Tsai
Corporate Officer/Principal bij TaiGen Biotechnology Co., Ltd.
Profiel
Chen En Tsai is currently working as the Vice President-Clinical Development at TaiGen Biotechnology Co., Ltd.
He previously worked as a Medical Advisor at Bristol-Myers Squibb (Taiwan) Ltd.
Dr. Tsai holds a doctorate degree from the University of Cambridge and National Taiwan University.
Actieve functies van Chen En Tsai
| Bedrijven | Functie | Begin |
|---|---|---|
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Corporate Officer/Principal | 01-12-2011 |
Eerdere bekende functies van Chen En Tsai
| Bedrijven | Functie | Einde |
|---|---|---|
| Bristol-Myers Squibb (Taiwan) Ltd. | Corporate Officer/Principal | - |
Opleiding van Chen En Tsai
| University of Cambridge | Doctorate Degree |
| National Taiwan University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
| Bristol-Myers Squibb (Taiwan) Ltd. |
